Medifast, Inc. (LON:0K05)
 11.94
 -0.17 (-1.41%)
  At close: Oct 31, 2025
Medifast Balance Sheet
Financials in millions USD. Fiscal year is January - December.
 Millions USD. Fiscal year is Jan - Dec.
Fiscal Year  | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 | 
|---|---|---|---|---|---|---|---|
Period Ending  | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 | 
Cash & Equivalents     | 99.53 | 90.93 | 94.44 | 87.69 | 104.18 | 163.72 | Upgrade   | 
Short-Term Investments     | 73.99 | 71.42 | 55.6 | - | 5.36 | 10.75 | Upgrade   | 
Cash & Short-Term Investments     | 173.51 | 162.34 | 150.04 | 87.69 | 109.54 | 174.48 | Upgrade   | 
Cash Growth     | 2.09% | 8.20% | 71.10% | -19.95% | -37.21% | 88.26% | Upgrade   | 
Inventory     | 23.21 | 42.42 | 54.59 | 118.86 | 180.04 | 53.39 | Upgrade   | 
Prepaid Expenses     | 6.82 | 9.64 | 10.67 | 16.24 | 16.33 | 6.45 | Upgrade   | 
Other Current Assets     | 4.3 | - | 8.73 | - | 0.95 | - | Upgrade   | 
Total Current Assets     | 207.84 | 214.4 | 224.03 | 222.78 | 306.87 | 234.31 | Upgrade   | 
Property, Plant & Equipment     | 41.24 | 48.68 | 67.11 | 75.65 | 80.59 | 38.14 | Upgrade   | 
Long-Term Deferred Tax Assets     | 12.11 | 11.46 | 4.12 | 5.33 | 4.4 | 0.69 | Upgrade   | 
Other Long-Term Assets     | 7.02 | 9.67 | 14.65 | 12.46 | 6.47 | 2.94 | Upgrade   | 
Total Assets     | 268.21 | 284.21 | 309.91 | 316.21 | 398.33 | 276.08 | Upgrade   | 
Accounts Payable     | 41.24 | 23.05 | 39.19 | 53.12 | 70.89 | 36.09 | Upgrade   | 
Accrued Expenses     | - | 23.3 | 36.48 | 49.03 | 67.18 | 50.15 | Upgrade   | 
Current Portion of Leases     | 5.47 | 6.18 | 5.89 | 5.78 | 6.52 | 3.67 | Upgrade   | 
Current Income Taxes Payable     | - | 1.49 | - | 0.43 | - | - | Upgrade   | 
Current Unearned Revenue     | - | 0.32 | 0.57 | 7.36 | 8.05 | 7.61 | Upgrade   | 
Other Current Liabilities     | - | 9.82 | 10.17 | 25.19 | 17.19 | 13.83 | Upgrade   | 
Total Current Liabilities     | 46.71 | 64.16 | 92.3 | 140.89 | 169.83 | 111.35 | Upgrade   | 
Long-Term Leases     | 6.79 | 9.94 | 16.13 | 20.28 | 26.02 | 7.49 | Upgrade   | 
Total Liabilities     | 53.5 | 74.1 | 108.43 | 161.17 | 195.85 | 118.84 | Upgrade   | 
Common Stock     | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade   | 
Additional Paid-In Capital     | 38.23 | 33.14 | 26.57 | 21.56 | 12.02 | 7.84 | Upgrade   | 
Retained Earnings     | 176.24 | 176.78 | 174.65 | 139.85 | 190.33 | 154.35 | Upgrade   | 
Treasury Stock     | - | - | - | -6.4 | - | -5 | Upgrade   | 
Comprehensive Income & Other     | 0.22 | 0.18 | 0.25 | 0.02 | 0.11 | 0.04 | Upgrade   | 
Shareholders' Equity     | 214.71 | 210.11 | 201.48 | 155.04 | 202.47 | 157.25 | Upgrade   | 
Total Liabilities & Equity     | 268.21 | 284.21 | 309.91 | 316.21 | 398.33 | 276.08 | Upgrade   | 
Total Debt     | 12.26 | 16.13 | 22.01 | 26.05 | 32.54 | 11.16 | Upgrade   | 
Net Cash (Debt)     | 161.25 | 146.22 | 128.03 | 61.64 | 77 | 163.31 | Upgrade   | 
Net Cash Growth     | 5.86% | 14.21% | 107.70% | -19.95% | -52.85% | 106.53% | Upgrade   | 
Net Cash Per Share     | 14.69 | 13.34 | 11.72 | 5.47 | 6.52 | 13.78 | Upgrade   | 
Filing Date Shares Outstanding     | 10.99 | 10.66 | 10.78 | 10.78 | 11.5 | 11.72 | Upgrade   | 
Total Common Shares Outstanding     | 10.99 | 10.66 | 10.78 | 10.81 | 11.55 | 11.72 | Upgrade   | 
Working Capital     | 161.13 | 150.24 | 131.73 | 81.89 | 137.03 | 122.96 | Upgrade   | 
Book Value Per Share     | 19.53 | 19.71 | 18.69 | 14.34 | 17.53 | 13.41 | Upgrade   | 
Tangible Book Value     | 214.71 | 210.11 | 201.48 | 155.04 | 202.47 | 157.25 | Upgrade   | 
Tangible Book Value Per Share     | 19.53 | 19.71 | 18.69 | 14.34 | 17.53 | 13.41 | Upgrade   | 
Land     | - | 0.35 | 0.57 | 0.57 | 0.57 | 0.57 | Upgrade   | 
Buildings     | - | 21.35 | 24.5 | 25.91 | 23.52 | 13.01 | Upgrade   | 
Machinery     | - | 44.97 | 50.44 | 49.38 | 42.85 | 21.1 | Upgrade   | 
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.